Food Safety News - December 26, 2017 U.S., Canada: under-the-radar ingredient implications

Food Safety News

U.S., Canada: under-the-radar ingredient implications

By Kelsey M. Mackin

Already the focus of two warning letters from Health Canada this year, Lithium orotate is a “questionable ingredient” used in some products for treating psychiatric disorders. However, NutraIngredients says that similar products are sold ‘south of the border’, and contain the salt mineral, but have not raised as high a concern for the U.S. Food and Drug Administration (FDA). Advocates of orotates claim support of the salt’s ability (as an orotic acid) to deliver trace... Continue Reading

FSIS inspection personnel report on "key 2017 achievements"

By News Desk

The U.S. Department of Agriculture's (USDA) Food Safety and Inspection Service (FSIS) is out with its report card of “key 2017 achievements in protecting public health, preventing foodborne illness and promoting confidence in the U.S. food supply.” In 2017, FSIS says it inspected more than 155 million head of livestock and 9.45 billion poultry carcasses.... Continue Reading

Listeria is the latest pathogen to rock Scotland's Errington Cheese

By News Desk

Two days before Christmas, Scotland’s troubled Errington Cheese Ltd. recalled all batches, all sizes, and all date codes of its Dunsyre Blue cheese because the product contains Listeria monocytogenes. The recall notice puts Errington’s Dunsyre Blue back in the news just two months after the Crown decided not to prosecute the company for the product.... Continue Reading

More Food Safety News

Food Safety News Copyright 2016 Marler Clark LLP, PS. All rights reserved.
Marler Clark LLP, PS, 1301 2nd Avenue
Suite 2800
Seattle WA 98101

Change your address or unsubscribe.
* To unsubscribe from updates, click the link above, click the unsubscribe link sent to your email, then toggle the subscription settings to "Unsubscribe".

You're receiving this newsletter because you are subscribed to Food Safety News
Not interested anymore? Unsubscribe. Having trouble viewing this email? View it in your browser.

No comments:

Post a Comment